Skip to main content
Equibles

PRICE T ROWE ASSOCIATES INC /MD/

Position in VERU — Veru Inc.

CIK 80255 BALTIMORE, MD
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$77,514
+$35,500 QoQ
Shares Held
24,765
+30.3% QoQ
Ownership
0.145%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 61 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. VERU ranks #288 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 2,678,047 $2,484,611,664
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,529,709 $953,834,749
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,728,421 $858,558,562
4 KYMR
Kymera Therapeutics, Inc.
 7,112,980 $815,645,416
5 RPRX
Royalty Pharma plc
 11,193,657 $627,628,347
6 RVMD
Revolution Medicines, Inc.
 2,969,853 $447,655,945
7 MRNA
Moderna, Inc.
 5,589,560 $391,436,886
8 TWST
Twist Bioscience Corp
 3,634,652 $373,932,997

All Filings in VERU

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $77,514 24,765
2026-03-31 $42,014 19,011
2025-12-31 $40,683 19,011
2025-09-30 $72,241 19,011
2025-06-30 $110,266 190,115
2025-03-31 $124,058 253,180
2024-12-31 $68,970 106,109
2024-09-30 $81,703 106,109
2024-06-30 $89,131 106,109
2024-03-31 $44,310 63,300
2023-12-31 $45,576 63,300
2023-09-30 $18,216 25,300
2023-06-30 $30,107 25,300
2023-03-31 $61,098 52,671
2022-12-31 $215,746 40,861
2022-09-30 $455,408 39,532
2022-06-30 $912,859 80,784
2022-03-31 $325,474 67,386
2021-12-31 $387,479 65,786
2021-09-30 $428,538 50,239
2021-06-30 $315,851 39,139
2021-03-31 $332,670 30,860
2020-12-31 $295,561 34,169
2020-09-30 $87,426 33,369